Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues

Growth Hormone and IGF Research

Volumn 18, Issue 2, 2008, Pages 148-156

  Sotelo, A I ^a   Miquet, J G ^a   Gonzalez L ^a   Bartke, A ^b   Turyn, D ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Section of Colorectal Surgery   (United States)

Author keywords

CIS; GH; GH desensitization; GH signaling; GHR; SOCS; STAT5; Vitamin D

Indexed keywords

COLECALCIFEROL; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; PHOSPHATE; STAT5 PROTEIN; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; FEMALE; GENE OVEREXPRESSION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER; MALE; MOUSE; MUSCLE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TREATMENT DURATION;

EID: 39749122659     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.08.001     Document Type: Article

References (49)

1. LeRoith D., Bondy C., Yakar S., Liu J.L., and Butler A. The somatomedin hypothesis. Endocrine Rev. 22 (2001) 47-53
2. Waters M.J., Hoang H.N., Fairlie D.P., Pelekanos R.A., and Brown R.J. New insights into growth hormone action. J. Mol. Endocrinol. 36 (2006) 1-7
3. Zhu T., Goh E.L.K., Graichen R., Ling L., and Lobie P.E. Signal transduction via the growth hormone receptor. Cell Signal. 13 (2001) 599-616
4. Sadowski C.L., Wheeler T.T., Wang L.H., and Sadowski H.B. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 142 (2001) 3890-3900
5. Udy G.B., Towers R.P., Snell R.G., et al. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7239-7244
6. Davey H.W., Xie T., McLachlan M.J., Wilkins R.J., Waxman D.J., and Grattan D.R. STAT5b is required for GH-induced liver IGF-I gene expression. Endocrinology 142 (2001) 3836-3841
7. Woelfle J., Billiard J., and Rotwein P. Acute control of insulin-like growth factor-I gene transcription by growth hormone through STAT5b. J. Biol. Chem. 278 (2003) 22696-22702
8. Woelfle J., and Rotwein P. In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E393-E401
9. Wormald S., and Hilton D.J. Inhibitors of cytokine signal transduction. J. Biol. Chem. 279 (2004) 821-824
10. Ram P., and Waxman D.J. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J. Biol. Chem. 275 (2000) 39487-39496
11. Matsumoto A., Masuhara M., Mitsui K., et al. is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89 (1997) 3148-3154
12. Landsman T., and Waxman D.J. Role of the cytokine-induced SH2-containing protein CIS in the growth hormone receptor internalization. J. Biol. Chem. 280 (2005) 37471-37480
13. Starr R., Willson T.A., Viney E.M., et al. A family of cytokine-inducible inhibitors of signaling. Nature 387 (1997) 917-921
14. Greenhalgh C.J., and Alexander W.S. Suppressors of cytokine signaling and regulation of growth hormone action. GH IGF Res. 14 (2004) 200-206
15. Davey H.W., McLachlan M.J., Wilkins R.J., Hilton D.J., and Adams T.E. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell. Endocrinol. 158 (1999) 111-116
16. DeLuca H. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80 (2004) 1689S-1696S
17. Holick M.F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 116 (2006) 2062-2072
18. Morales O., Faulds M.H., Lindgren U.J., and Haldosen L.A. 1α,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. J. Biol. Chem. 277 (2002) 34879-34884
19. González L., Miquet J.G., Sotelo A.I., Bartke A., and Turyn D. Cytokine-inducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice. Endocrinology 143 (2002) 286-294
20. Miquet J.G., Sotelo A.I., Bartke A., and Turyn D. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 145 (2004) 2824-2832
21. Mayo K.E., Hammer R.E., Swanson L.W., Brinster R.L., Rosenveld M.G., and Evans R.M. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone releasing factor gene. Mol. Endocrinol. 2 (1988) 606-612
22. Canaff L., and Hendy G.N. Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxy vitamin D. J. Biol. Chem. 277 (2002) 30337-30350
23. Tsuruoka S., Nishiki K., Sugimoto K., and Fujimura A. Time of day improves efficacy and reduces adverse reactions of vitamin D3 in 5/6 nephrectomized rat. Life Sci. 71 (2002) 1809-1820
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
25. Miquet J.G., Sotelo A.I., Bartke A., and Turyn D. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E600-E607
26. Segura C., Alonso M., Fraga C., Garcia-Caballero T., and Pérez-Fernández R. Vitamin D receptor ontogenesis in rat liver. Histochem. Cell. Biol. 112 (1999) 163-167
27. Bischoff H.A., Borchers M., Gudat F., Duermueller U., Theiler R., Stahelin H.B., and Dick W. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33 (2001) 19-24
28. Gascón-Barre M., Demers C., Mirshahi A., Neron S., Zalzal S., and Nancy A. The normal livers harbors the vitamin D nuclear receptor in nonparenchymal and biliary ephitelial cells. Hepatology 37 (2003) 1034-1042
29. Bernardi R.J., Johnson C.S., Modzelewski R.A., and Trump D.L. Antiproliferative effects of 1α,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells. Endocrinology 143 (2002) 2508-2514
30. Sandgren M.E., Bronnegard M., and DeLuca H.F. Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem. Biophys. Res. Commun. 181 (1991) 611-616
31. Jensen S.S., Madsen M.W., Lukas J., Binderup L., and Bartek J. Inhibitory effects of 1α,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol. Endocrinol. 15 (2001) 1370-1380
32. Rixon R.H., Isaacs R.J., and Whitfield J.F. Control of DNA polymerase-alpha activity in regenerating rat liver by calcium and 1-alpha,25(OH)2D3. J. Cell. Physiol. 139 (1989) 354-360
33. Taniguchi K., Morimoto S., Itoh K., Morita R., Fukuo K., Imanaka S., and Ogihara T. Stimulatory effect of 1,25-dihydroxyvitamin D3 on transferrin synthesis in primary cultures of adult rat hepatocytes. Biochem. Int. 22 (1990) 37-44
34. Simpson R.U., Thomas G.A., and Arnold A.J. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J. Biol. Chem. 260 (1985) 8882-8891
35. Capiati D., Benassati S., and Boland R.L. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell. Biochem. 86 (2002) 128-135
36. Endo I., Inoue D., Mitsui T., et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144 (2003) 5138-5144
37. Hull K.L., and Harvey S. Growth hormone therapy and quality of life: possibilities, pitfalls and mechanisms. J. Endocrinol. 179 (2003) 311-333
38. Toogood A.A. Growth hormone (GH) status and body composition in normal ageing and in elderly adults with GH deficiency. Horm. Res. 60 Suppl. 1 (2003) 105-111
39. Simpson H., Savine R., Sonksen P., et al. Growth hormone replacement therapy for adults: into the new millennium. GH IGF Res. 12 (2002) 1-33
40. Dominici F.P., Argentino D.P., Muñoz M.C., Miquet J.G., Sotelo A.I., and Turyn D. Influence of the crosstalk between growth hormone and insulin signaling on the modulation of insulin sensitivity. GH IGF Res. 15 (2005) 324-336
41. Adams T.E., Hansen J.A., Starr R., Nicola N.A., Hilton D.J., and Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273 (1998) 1285-1287
42. Tollet-Egnell P., Flores-Morales A., Stavréus-Evers A., Sahlin L., and Norstedt G. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140 (1999) 3693-3714
43. Karlsson H., Gustafsson J.A., and Mode A. CIS desensitizes GH-induced Stat5 signaling in rat liver cells. Mol. Cell. Endocrinol. 154 (1999) 37-43
44. Ram P., and Waxman D.J. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274 (1999) 35553-35561
45. L. González, L.M. Curto, J.G. Miquet, A. Bartke, D. Turyn, A.I. Sotelo, Differential regulation of membrane associated-growth hormone binding protein (MA-GHBP) and growth hormone receptor (GHR) expression by growth hormone (GH) in mouse liver. GH IGF Res. (2007), doi:10.1016/j.ghir.2006.12.002.
46. Iida K., del Rincon J.P., Kim D.S., Itoh E., Coschigano K., Kopchick J.J., and Thorner M.O. Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E566-E573
47. Frost R.A., Nystrom G.J., and Lang C.H. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts. Endocrinology 143 (2002) 492-503
48. Waxman D.J., Ram P.A., Park S.H., and Choi H.K. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, STAT5-related DNA binding protein. Proposed role as an intracelular regulator of male-specific liver gene transcription. J. Biol. Chem. 270 (1995) 13262-13270
49. Gebert C.A., Park S.H., and Waxman D.J. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous GH stimulation. Mol. Endocrinol. 13 (1999) 213-227